fbpx
Ă—
Illustrations by Maura McNamara

5 Women in Psychedelics You Should Know About

Badass women making waves in the psychedelic movement, from research to drug policy reform

Michelle Janikian // Dec. 2, 2019

DoubleBlind is devoted to fair, rigorous reporting by leading experts and journalists in the field of psychedelics. Read more about our editorial process and fact-checking here. Editorially reviewed by Madison Margolin.

Women have always played an integral role in psychedelic healing and research, even if they haven’t always been highlighted as mavericks in the field. But as the “Psychedelic Renaissance” goes mainstream, it’s time to start recognizing groundbreaking women in psychedelic science and activism. The five women we’ve chosen to feature are all actively changing the landscape of psychedelics, from developing leading theories in how they work, to advocating for fair access for all. These women, among many other women and gender non-conforming folk, are shifting the way society and science view these substances and bringing forth a new generation of doctors, researchers, and policymakers, with psychedelics at the core.

Ann Shulgin

DoubleBlind: Ann Shulgin

Born in 1931, Ann Shulgin is often seen as a matriarch of the psychedelic movement. Before MDMA was classified as a Schedule I substance in 1985, and then 2C-B in 1995, Shulgin provided psychedelic-assisted therapy with these substances for many in the Bay Area using her expertise in Jungian psychology. She is the widow of the renowned chemist, Alexander “Sasha” Shulgin, who had a license from the DEA to essentially invent new psychedelic compounds and test them on himself, synthesizing over 230 new psychoactive compounds in the process, including 2C-B. Together, they co-wrote two classic psychedelic books, PIHKAL: A Chemical Love Story and TIHKAL: The Continuation, detailing those substances, including their own rating scale to judge the personal effects. Ann Shulgin is also the Founder of Transform Press, has contributed to many other books and publications on the subject, including Ecstasy: The Complete Guide and The Secret Chief Revealed, and continues to write and speak on psychedelic issues.

Monnica Williams

DoubleBlind: Monnica Williams

Monnica Williams, Ph.D., is a clinical psychologist, researcher and professor who’s dedicated to expanding psychedelic-assisted therapy access to minorities and people of color (POC). She’s a trained MDMA-assisted therapist and has worked on Multidisciplinary Association for Psychedelic Studies (MAPS) PTSD trials, including the only site exclusively available to POC. As an expert in race-based trauma, Williams is working with MAPS on making MDMA-assisted therapy more inviting and inclusive to marginalized communities by training more therapists of color and tweaking certain aspects of the protocol, like the language and music used. Williams is also the Clinical Director of the Behavioral Wellness Clinic in Connecticut as well as the Associate Director of the Chacruna Institute for Psychedelic Plant Medicines, a publication and organization that bridges the divide between sacred entheogenic traditions and current psychedelic science. To bring light to racial disparities and cultural differences in treating anxiety disorders, Williams has authored over 100 peer-reviewed papers as well as articles and book chapters in her field.

Rosalind “Ros” Watts

DoubleBlind: Ros Watts

DoubleBlind presents: How to grow mushrooms online course. Let's Shroom!

Rosalind Watts, Ph.D. is the clinical lead of groundbreaking trials on psilocybin for depression at Imperial College London. Through her experience guiding many psilocybin-assisted therapy sessions in her work at Imperial, she has written several key scientific papers on the subjective psilocybin experience and psychological mechanisms of post-trip changes. Themes she explores in her work, like psilocybin’s ability to connect people with themselves, others, and the world, and to help people move from “avoidance to acceptance” of difficult emotions, is shaping how the psychedelic and scientific communities explain how mushrooms work for relieving mental health conditions. Based on this work, Watts has recently developed the ACE Model (Accept, Connect, Embody) to provide psychedelic therapists with a framework on how to work with a depressed population.

Bia Labate

DoubleBlind: Bia Labate of Chacruna

Bia Labate, Ph.D., is an anthropologist from Brazil with a focus on psychoactive substances, drug policies, shamanism, and religion. She is involved in the psychedelic movement as the Executive Director of Chacruna, and organizes and speaks at many events in the community. Labate is also the Public Education and Culture Specialist at MAPS, adjunct professor at the California Institute of Integral Studies (CIIS), visiting professor at the University of Guadalajara, Mexico, and author of over 20 books and several peer-reviewed papers. She is a huge proponent of including more diverse voices in the psychedelic community, especially of queer, women/non-binary, Latinx, and indigenous folks in these important and societal-shifting conversations.

Natalie Ginsberg

DoubleBlind: Natalie Ginsberg of MAPS

Natalie Lyla Ginsberg, M.S.W., is the Director of Policy and Advocacy at MAPS where she lobbies in support of cannabis and psychedelic research and policy change. She is dedicated to building and organizing the psychedelic community as well as pushing these issues to the front of social change. Ginsberg originally got involved in advocacy work after her experience as a social worker in low-income neighborhoods in New York City where she became frustrated with systemic failures making it impossible for her clients to succeed. Before joining MAPS in 2014, she worked as a policy fellow with the Drug Policy Alliance and helped to bring medical cannabis to New York state in an attempt to end racist marijuana arrests. Now, in coordination with MAPS and Imperial College London, she is co-developing a psychedelic peace-building strategy between Israelis and Palestinians, inspired by the potential of these substances to heal systemic, intergenerational trauma and build community.

Michelle Janikian is a journalist focused on drug policy, trends and education. She’s the author of the upcoming book, “Your Psilocybin Mushroom Companion: An Informative, Easy-to-Use Guide to Understanding Magic Mushrooms”, writes a column for Playboy about psychedelics and cannabis and has also contributed to High Times, Herb, Rolling Stone and Teen Vogue.

We have a small favor to ask. In 2020, more than five million readers like you visited DoubleBlind’s website. Many of them are suffering and simply seeking trusted information on how to use psychedelics to heal.

We started DoubleBlind two years ago at a time when even the largest magazines and media companies were cutting staff and going out of business. Friends and family said we were crazy. But we did it anyway, because we believe in it—deeply. We believe in the value of good journalism. And we believe in the extraordinary potential of psychedelics to reduce suffering. At the time we made a commitment: we will never have a paywall, we will never rely on advertisers we don’t believe in to fund our reporting, and we will always be accessible via email and social media to support people for free on their journeys with plant medicines.

To help us do this, if you feel called and can afford it, we ask you to consider making a monthly donation to DoubleBlind, starting at $1. In exchange, you’ll be invited to a monthly Zoom call with DoubleBlind’s co-founders, Shelby Hartman and Madison Margolin, where they’ll answer any questions you have about the psychedelic movement or your own journey with psychedelics. These Zoom calls also include special guests, some of the people who we love and respect most in the psychedelic space. Together, we brainstorm, collaborate, dialogue, and, simply, commune. Either way, please know that we value you as a member of our community. Make a gift now from as little as $1. Thank you.

Donate now
Michelle Janikian is a journalist and the author of Your Psilocybin Mushroom Companion, the down-to-earth guide that details everything you need to know about taking magic mushrooms safely and mindfully, published by Ulysses Press. Michelle actively covers psychedelic and cannabis education, harm reduction, and research in her work. She writes a column for Playboy about psychedelics and cannabis, and has also contributed to Rolling Stone, High Times, Psychedelics Today, Herb, and others. She’s passionate about the healing potential of psychedelic plants and substances, and the legalization and destigmatization of all drugs. Born in New York City and raised in New Jersey, Michelle studied writing and psychology at Sarah Lawrence College before traveling extensively in Latin America and eventually settling down in Southern Mexico. Michelle was recently awarded the Cosmic Sister Emerging Voices Award for her work covering the psychedelic renaissance. When she’s not writing or speaking publicly about the magic of mushrooms, she can be found wandering the woods with her two rescue dogs or enjoying her third cup of coffee with a good book. You can read more about Michelle’s drug policy reporting on her LinkedIn, or follow her on Twitter and Instagram.

share

fb-black
FEATURES

Jewish and Transgender

The journey to authenticity means reconciling the various parts of who we are
COLUMNS

Prescription Psychedelics are Almost Here—But Western Medicine Isn’t Ready

A paradigm shift needs to happen as psychedelics go legal. PEACH—Psychedelic Education and Community Healing—is the path forward.
COLUMNS

The Meaning of Life—According to Neuroscience

A modern spin on an old argument.